Ground-glass opacity nodules: Histopathology, imaging evaluation, and clinical implications

Journal of Thoracic Imaging

Volumn 26, Issue 2, 2011, Pages 106-118

  Lee, Ho Yun ^a   Lee, Kyung Soo ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

bronchioloalveolar carcinoma; Ground glass opacity; imaging; lung adenocarcinoma; prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; K RAS PROTEIN;

ATYPICAL ADENOMATOUS HYPERPLASIA; CANCER ADJUVANT THERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FOLLOW UP; GENE MUTATION; GROUND GLASS OPACITY NODULE; HISTOPATHOLOGY; HUMAN; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG LAVAGE; LUNG LOBECTOMY; LUNG NODULE; LUNG RESECTION; LUNG SCINTISCANNING; LUNG SMALL CELL CANCER; LUNG VOLUME; MINIMALLY INVASIVE SURGERY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION DOSE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STANDARDIZED UPTAKE VALUE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; CONTRAST MEDIA; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PRECANCEROUS CONDITIONS; PROGNOSIS; RADIOPHARMACEUTICALS; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 79955556995     PISSN: 08835993     EISSN: 15360237     Source Type: Journal    
DOI: 10.1097/RTI.0b013e3181fbaa64     Document Type: Conference Paper

References (66)

1. Henschke CI, Yankelevitz DF, Mirtcheva R, et al. CT screening for lung cancer: frequency and significance of partsolid and nonsolid nodules. AJR Am J Roentgenol. 2002; 178:1053-1057. (Pubitemid 34411393)
2. Ko JP. Lung nodule detection and characterization with multislice CT. J Thorac Imaging. 2005;20:196-209. (Pubitemid 41193213)
3. Kim HY, Shim YM, Lee KS, et al. Persistent nodular groundglass opacity at thin-section CT: histopathologic comparisons. Radiology. 2007;245:267-275.
4. Godoy MC, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. Radiology. 2009;253:606-622.
5. Infante M, Lutman RF, Imparato S, et al. Differential diagnosis and management of focal ground-glass opacities. Eur Respir J. 2009;33:821-827.
6. Park CM, Goo MJ, Kim TJ, et al. Pulmonary nodular groundglass opacities in patients with extrapulmonary cancers: what is their clinical significance and how can we determine whether they are malignant or benign lesions? Chest. 2008;133: 1402-1409. (Pubitemid 351892997)
7. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and genetics of tumors of the lung, pleura, thymus, and heart. In: World Health Organization Classification of Tumours. Lyon, France: IARC Press; 2004.
8. Ikeda K, Awai K, Mori T, et al. Differential diagnosis of ground glass opacity nodules: CT number analysis by threedimensional computerized quantification. Chest. 2007;132: 984-990.
9. Ullmann R, Bongiovanni M, Halbwedl I, et al. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma? J Pathol. 2003;201:371-376. (Pubitemid 37408257)
10. Yokose T, Doi M, Tanno K, et al. Atypical adenomatous hyperplasia of the lung in autopsy cases. Lung Cancer. 2001; 33:155-161. (Pubitemid 32707896)
11. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol. 2005;40:90-97. (Pubitemid 40417889)
12. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol. 2005;23:3279-3287. (Pubitemid 46211352)
13. Brambilla E, Travis W. The new ERS/IASLC/ATS classification of lung adenocarcinoma: introduction and pathology. J Thorac Oncol. 2010;5:S29.
14. Miyake H, Matsumoto A, Terada A, et al. Mucin-producing tumor of the lung: CT findings. J Thorac Imaging. 1995;10: 96-98.
15. Sakamoto H, Shimizu J, Horio Y, et al. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol. 2007;212:287-294. (Pubitemid 47010062)
16. Lee HY, Lee KS, Han J, et al. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons. Lung Cancer. 2009;65:170-175.
17. Kushihashi T, Munechika H, Ri K, et al. Bronchioloalveolar adenoma of the lung: CT-pathologic correlation. Radiology. 1994;193:789-793. (Pubitemid 24366955)
18. Suzuki K, Kusumoto M, Watanabe S, et al. Radiologic classification of small adenocarcinoma of the lung: radiologicpathologic correlation and its prognostic impact. Ann Thorac Surg. 2006;81:413-420.
19. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer. 1995;75:2844-2852.
20. Kim BT, Kim Y, Lee KS, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol. 1998;170:935-939. (Pubitemid 28172876)
21. Maeda R, Isowa N, Onuma H, et al. The maximum standardized uptake values on positron emission tomography to predict the Noguchi classification and invasiveness in clinical stage IA adenocarcinoma measuring 2 cm or less in size. Interact Cardiovasc Thorac Surg. 2009;9:70-73.
22. Chun EJ, Lee HJ, Kang WJ, et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: the feasibility of integrated (18)F-FDG PET/CT. Lung Cancer. 2009;65:180-186.
23. Kishi K, Homma S, Kurosaki A, et al. Small lung tumors with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer. 2004;44: 43-51. (Pubitemid 38317261)
24. Nakata M, Sawada S, Saeke H, et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann Thorac Surg. 2003; 75:1601-1606; discussion 1605-1606.
25. Miller TW. Radiographic evaluation of the chest. In: Fishman AP, ed. Pulmonary Disease and Disorders. 2nd ed. New York: McGraw-Hill; 1988:479-527.
26. Min JH, Lee HY, Lee KS, et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer. 2010;69:123-126.
27. Dumont P, Gasser B, Rouge C, et al. Bronchioloalveolar carcinoma: histopathologic study of evolution in a series of 105 surgically treated patients. Chest. 1998;113:391-395. (Pubitemid 28110016)
28. Lindell RM, Hartman TE, Swensen SJ, et al. 5-year lung cancer screening experience: growth curves of 18 lung cancers compared to histologic type, CT attenuation, stage, survival, and size. Chest. 2009;136:1586-1595.
29. Takashima S, Sone S, Li F, et al. Indeterminate solitary pulmonary nodules revealed at population-based CT screening of the lung: using first follow-up diagnostic CT to differentiate benign and malignant lesions. AJR Am J Roentgenol. 2003; 180:1255-1263. (Pubitemid 36504611)
30. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol. 2000;73:1252-1259. (Pubitemid 32123826)
31. Kakinuma R, Ohmatsu H, Kaneko M, et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J Comput Assist Tomogr. 2004;28:17-23. (Pubitemid 38057850)
32. Marten K, Auer F, Schmidt S, et al. Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria. Eur Radiol. 2006;16:781-790. (Pubitemid 43380236)
33. Ko JP, Rusinek H, Jacobs EL, et al. Small pulmonary nodules: volume measurement at chest CT-phantom study. Radiology. 2003;228:864-870. (Pubitemid 37025500)
34. de Hoop B, Gietema H, van de Vorst S, et al. Pulmonary ground-glass nodules: increase in mass as an early indicator of growth. Radiology. 2010;255:199-206.
35. Nomori H, Ohtsuka T, Naruke T, et al. Differentiating between atypical adenomatous hyperplasia and bronchioloalveolar carcinoma using the computed tomography number histogram. Ann Thorac Surg. 2003;76:867-871. (Pubitemid 37100762)
36. Oda S, Awai K, Liu D, et al. Ground-glass opacities on thinsection helical CT: differentiation between bronchioloalveolar carcinoma and atypical adenomatous hyperplasia. AJR Am J Roentgenol. 2008;190:1363-1368. (Pubitemid 351684900)
37. Aoki T, Nakata H, Watanabe H, et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. AJR Am J Roentgenol. 2000; 174:763-768. (Pubitemid 30126259)
38. Terasaki H, Niki T, Matsuno Y, et al. Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol. 2003;27:937-951. (Pubitemid 36758897)
39. Sakao Y, Miyamoto H, Sakuraba M, et al. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thorac Surg. 2007;83:209-214. (Pubitemid 44917878)
40. Kobayashi N, Toyooka S, Ichimura K, et al. Non-BAC component but not epidermal growth factor receptor gene mutation is associated with poor outcomes in small adenocarcinoma of the lung. J Thorac Oncol. 2008;3:704-710.
41. Okada M, Tauchi S, Iwanaga K, et al. Associations among bronchioloalveolar carcinoma components, positron emission tomographic and computed tomographic findings, and malignant behavior in small lung adenocarcinomas. J Thorac Cardiovasc Surg. 2007;133:1448-1454. (Pubitemid 46802632)
42. Takamochi K, Nagai K, Yoshida J, et al. Pathologic no status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg. 2001; 122:325-330.
43. Kim EA, Johkoh T, Lee KS, et al. Quantification of groundglass opacity on high-resolution CT of small peripheral adenocarcinoma of the lung: pathologic and prognostic implications. AJR Am J Roentgenol. 2001;177:1417-1422. (Pubitemid 33081493)
44. Aoki T, Tomoda Y, Watanabe H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology. 2001; 220:803-809. (Pubitemid 32799993)
45. Lee HY, Han J, lee KS, et al. Lung adenocarcinoma as a solitary pulmonary nodule: prognostic determinants of CT, PET and histopathologic findings. Lung Cancer. 2009;66: 379-385.
46. Yanagawa M, Tanaka Y, Kusumoto M, et al. Automated assessment of malignant degree of small peripheral adenocarcinomas using volumetric CT data: correlation with pathologic prognostic factors. Lung Cancer. [Epub ahead of print]. Available at: doi:10.1016/j.lungcan.2010.03.009. Accessed April 13, 2010.
47. Finberg KE, Sequist LV, Joshi VA, et al. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features. J Mol Diagn. 2007;9: 320-326. (Pubitemid 47305068)
48. Inamura K, Ninomiya H, Ishikawa Y, et al. Is the epidermal growth factor receptor status in lung cancers reflected in clinicopathologic features? Arch Pathol Lab Med. 2010; 134:66-72.
49. Mok TS, Wu YL, Yu CJ, et al. Randomized, placebocontrolled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer. J Clin Oncol. 2009;27:5080-5087.
50. Tang X, Shigematsu H, Bekele BN, et al. EGFR tyrosine kinase domain mutations are detected in histologically normal respiratory epithelium in lung cancer patients. Cancer Res. 2005;65:7568-7572. (Pubitemid 41297226)
51. Yatabe Y, Takahashi T, Mitsudomi T. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer. Cancer Res. 2008;68:2106-2111. (Pubitemid 351521782)
52. Yano M, Sasaki H, Kobayashi Y, et al. Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma. J Thorac Oncol. 2006;1:413-416. (Pubitemid 47181416)
53. Vesselle H, Salskov A, Turcotte E, et al. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index. J Thorac Oncol. 2008; 3:971-978.
54. Chung J-H, Choe G, Jheon S, et al. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread. J Thorac Oncol. 2009;4:1490-1495.
55. Lee HY, Goo JM, Lee HJ, et al. Usefulness of concurrent reading using thin-section and thick-section CT images in subcentimetre solitary pulmonary nodules. Clin Radiol. 2009; 64:127-132.
56. Funama Y, Awai K, Liu D, et al. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. J Comput Assist Tomogr. 2009;33:49-53.
57. Ohno Y, Koyama H, Kono A, et al. Influence of detector collimation and beam pitch for identification and image quality of ground glass attenuation and nodules on 16- and 64-detector row CT systems: experimental study using chest phantom. Eur J Radiol. 2007;64:406-413. (Pubitemid 350116497)
58. Brenner DJ. Radiation risks potentially associated with lowdose CT screening of adult smokers for lung cancer. Radiology. 2004;231:440-445. (Pubitemid 38552902)
59. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg. 2002;73:386-392; discussion 383-392. (Pubitemid 34117375)
60. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann Thorac Surg. 2003;76:1016-1022. (Pubitemid 37204698)
61. Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg. 2006;30: 160-163. (Pubitemid 43850329)
62. Watanabe S, Watanabe T, Arai K, et al. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann Thorac Surg. 2002;73:1071-1075. (Pubitemid 34275880)
63. Suzuki K, Asamura H, Kusumoto M, et al. "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg. 2002;74:1635-1639. (Pubitemid 35222657)
64. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol. 2004;28:198-206. (Pubitemid 38124728)
65. Gandara DR, West H, Chansky K, et al. Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition. Clin Cancer Res. 2004; 10:4205-4209.
66. Park JH, Lee KS, Kim JH, et al. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J Radiol. 2009;10:12-20.